Substance P/ Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link?

Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment

(2021) Riffat Mehboob   BIOMEDICINE & PHARMACOTHERAPY

Serotonin and substance P: Synergy or competition in the control of breathing

(2020) Małgorzata Szereda-Przestaszewska et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Covid-19 — The Search for Effective Therapy

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

(2020) Dennis McGonagle et al.   AUTOIMMUNITY REVIEWS

Infectious herpes simplex virus in the brainstem is correlated with reactivation in the trigeminal ganglia

(2019) Jessica R. Doll et al.   JOURNAL OF VIROLOGY

Neuropeptides and breathing in health and disease

(2018) Katarzyna Kaczyńska et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex

(2017) Fiona M. Bright et al.   PLoS One

Towards Better Understanding of the Pathogenesis of Neuronal Respiratory Network in Sudden Perinatal Death

(2017) Riffat Mehboob et al.   Frontiers in Neurology

Substance P/Neurokinin 1 and Trigeminal System: A Possible Link to the Pathogenesis in Sudden Perinatal Deaths

(2017) Riffat Mehboob   Frontiers in Neurology

Immunohistochemical Analysis of Brainstem Lesions in the Autopsy Cases with Severe Motor and Intellectual Disabilities Showing Sudden Unexplained Death

(2016) Masaharu Hayashi et al.   Frontiers in Neurology

Substance P Receptor Antagonism: A Potential Novel Treatment Option for Viral-Myocarditis

(2015) Prema Robinson et al.   Biomed Research International

HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P

(2014) Florin Tuluc et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Developmental alterations of the spinal trigeminal nucleus disclosed by substance P immunohistochemistry in fetal and infant sudden unexplained deaths

(2011) Anna M. Lavezzi et al.   NEUROPATHOLOGY

Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals

(2010) Mark M Manak et al.   AIDS

Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)

(2008) I. Chernova et al.   JOURNAL OF LEUKOCYTE BIOLOGY